Is antigen presentation the primary function of HLA-G?

Microbes and Infection

Volumn 3, Issue 4, 2001, Pages 323-332

  Le Bouteiller, Philippe ^a   Solier, Corinne ^a  

^a CHU PURPAN   (France)

Author keywords

CD8; HLA G; Innate immunity; Placenta; Pregnancy

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; HUMAN; IMMUNITY; IMMUNOMODULATION; PREGNANCY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0035031389     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01386-7     Document Type: Review

References (124)

1. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G
2. The functionality of HLA-G is emerging
3. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line
4. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment
5. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule
6. A class I antigen, HLA-G, expressed in human trophoblasts
7. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts
8. Placental HLA-G protein expression in vivo: Where and what for?
9. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens
10. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
11. The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells
12. The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface
13. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4
14. HLA class I chromosomal region, genes, and products: Facts and questions
15. The regulation of HLA class I expression: Is HLA-G the odd one out?
16. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue
17. Temporal and spatial expression of HLA-G messenger RNA in extraembryonic tissues of transgenic mice
18. The mRNA of a human class I gene HLA-G/HLA6.0 exhibits a restricted pattern of expression
19. Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation
20. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts
21. HLA-G in human thymus: A subpopulation of medullary epithelial but not CD83+ dendritic cells expresses HLA-G as a membrane-bound and soluble protein
22. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation
23. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules
24. Soluble HLA-G in human placentas: Synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts
25. Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy
26. Soluble HLA-G circulates in maternal blood during pregnancy
27. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma
28. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element
29. A candidate interferon-gamma activated site (GAS element) in the HLA-G promoter does not bind nuclear proteins
30. Primate MHC-E and -G alleles
31. Little evidence of HLA-G mRNA polymorphism in caucasian or afro-caribbean populations
32. The molecular descent of the major histocompatibility complex
33. Human NK-cell receptors
34. Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: The beginning of a story
35. The role of peptide presentation in the physiological function of HLA-G
36. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8
37. Cell-cell adhesion mediated by CD8 and MHC class I molecules
38. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8 aa
39. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations
40. Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor
41. Gamma(delta) T cells: Non-classical ligands for non-classical cells
42. An innate view of human pregnancy
43. Tubal versus uterine placentation: Similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment
44. Nonclassical HLA-G molecules are classical peptide presenters
45. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
46. Antigen processing and presentation by human trophoblast-derived cell lines
47. Calreticulin associates with non-HLA-A,-B class I proteins in the human choriocarcinoma cell lines JEG-3 and BeWo
48. Positive selection of an H2-M3 restricted T cell receptor
49. The selection of M3-restricted T cells is dependent on M3 expression and presentation of N-formylated peptides in the thymus
50. CTL and sequence analyses of MHC class IB antigens Qa1c (H2-T23r) and Qa1d (H2-T23f)
51. The MHC reactivity of the T cell repertoire prior to positive and negative selection
52. HLA-G functions as a restriction element and a transplantation antigen in mice
53. Cytotoxic T, lymphocyte recognition of HLA-G in mice
54. The role of trophoblast in the physiological change in decidual spiral arteries
55. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
56. Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection
57. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody
58. Induction of HLA-G-specific human CD8+ T cell lines by stimulation across a polymorphism of HLA-G
59. An evolutionary overview of the MHC-G polymorphism: Clues to the unknown function(s)
60. Impaired spontaneous endocytosis of HLA-G
61. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules
62. Viral strategies of immune evasion
63. Viral subversion of the immune system
64. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism
65. Interaction between the human NK receptors and their ligands
66. NK cell recognition of non-classical HLA class I molecules
67. Regulation of T cell function by NK cell receptors for classical MHC class I molecules
68. Plasticity in the organization and sequences of human KIR/ILT gene families
69. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans
70. Recognition of HLA-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer-cell mediated lysis
71. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
72. Natural killer cells fertile with receptors for HLA-G?
73. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
74. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
75. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
76. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
77. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells
78. p49, a putative Hla class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
79. A human histocompatibility leukocyte antigen (HLA)-G specific receptor expressed on all natural killer cells
80. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor
81. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells
82. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines
83. Immunology of human placental implantation: Clinical implications of our current understanding
84. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
85. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
86. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
87. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
88. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
89. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells
90. Immunology at the maternal-fetal interface: Lessons for T cell tolerance and suppression
91. Tolerance to the foeto-placental 'graft': Ten ways to support a child for nine months
92. HLA-G polymorphisms: Neutral evolution or novel function?
93. Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism
94. Cutting Edge: Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8
95. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes
96. Early pregnancy induces significant changes in soluble HLA levels
97. HLA and the maternal-fetal relationship
98. Human implantation: Cell biology and immunology
99. Elevated expression of activation molecules by decidual lymphocytes in women suffering spontaneous early pregnancy loss
100. Apoptotic nuclei within the uterine decidua of first trimester pregnancy arise from CD45 positive leukocytes
101. The role of T cell apoptosis in transplantation tolerance
102. Maternal-fetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand
103. Localisation of the Th2 cytokines IL-3, IL-4, IL-10 at the murine feto maternal interface during pregnancy
104. HLA-G suppresses proliferation of CD4+ T lymphocytes
105. HLA-G inhibits the allogeneic proliferative response
106. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response
107. CD1, tuberculosis, and the evolution of major histocompatibility complex molecules
108. Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies
109. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta
110. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia
111. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia
112. Review: Immunobiology of preeclampsia
113. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G
114. HLA-G inhibits the transendothelial migration of human NK cells
115. HLA class I molecules in the placenta: Which ones? Where? and What for? A workshop report
116. HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: A lesson learned from ectopic pregnancies
117. The expression of human leukocyte antigen-G on trophoblasts abolishes the growth-suppressing effect of interleukin-2 towards them
118. A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population
119. HLA-G1 protein expression is not essential for fetal survival
120. Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival
121. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes
122. A high-resolution view of NK-cell receptors: Structure and function
123. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homologue UL18
124. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain